INTRODUCTION: This randomized, placebo-controlled, double-blind, parallel study aimed to evaluate the effect of 3-month supplementation of bovine colostrum (BOV-COL; 8x400 mg per day) on the outcomes of depression treatment in hospitalized patients with substance use disorder (SUD). The hypothesis is that BOV-COL supplementation as an add-on treatment results in favorable alternations in selected blood inflammatory markers or neurotransmitters, leading to better depression treatment outcomes compared with placebo (PLA). METHODS: Patients with a Minnesota Multiphasic Personality Inventory-2 score ≥60 points were enrolled. Twenty-nine participants (n=18 in the BOV-COL group and n=11 in the PLA group) completed the protocol. RESULTS: The mean Beck Depression Inventory-II score was significantly reduced after supplementation in both groups. However, the mean 17-point Hamilton Depression Rating Scale score was decreased in the BOV-COL group, but not in the PLA group. In the BOV-COL group, there was a reduction in interleukin (IL)-1, IL-6, IL-10, the IL-6:IL-10 ratio, IL-17, and tumor necrosis factor alpha (TNF-α), while in the PLA group only IL-6 decreased. Favorable alternations in the total count and differentials of white blood cell subsets were more pronounced in the BOV-COL. There were no changes in neurotransmitter concentrations. CONCLUSIONS: BOV-COL supplementation is a promising add-on therapy in patients with depression and SUD.

Agrapak Company Poznań Poland

Department of Physiology and Biochemistry Poznań University of Physical Education Poznań Poland

Department of Sports Dietetics Poznań University of Physical Education Poznań Poland

Faculty of Physical Education Gdansk University of Physical Education and Sport Gdańsk Poland

Institute of Mental Health Para Familia Gorzów Wielkopolski Poland

Sport Sciences Biomedical Department Charles University Prague Czechia

Zobrazit více v PubMed

Espino-Salinas CH, Galván-Tejada CE, Luna-García H, Gamboa-Rosales H, Celaya-Padilla JM, Zanella-Calzada LA, et al. . Two-dimensional convolutional neural network for depression episodes detection in real time using motor activity time series of depresjon dataset. Bioengineering. (2022) 9:458. doi: 10.3390/bioengineering9090458 PubMed DOI PMC

Klengel T, Binder EB. Gene—Environment interactions in major depressive disorder. Can J Psychiatry. (2013) 58:76–83. doi: 10.1177/070674371305800203 PubMed DOI

Yamasaki K, Hasegawa T, Takeda M. Serum level of soluble interleukin 6 receptor is a useful biomarker for identification of treatment-resistant major depressive disorder. Neuropsychopharm Rep. (2020) 40:130–7. doi: 10.1002/npr2.12100 PubMed DOI PMC

Faris LH, Gabarrell-Pascuet A, Felez-Nobrega M, Cristóbal-Narváez P, Mortier P, Vilagut G, et al. . The association between substance use disorder and depression during the COVID-19 lockdown in Spain and the moderating role of social support: a cross-sectional study. Int J Ment Health Addict. (2023) 21:1157–67. doi: 10.1007/s11469-021-00651-7 PubMed DOI PMC

McHugh R. Alcohol use disorder and depressive disorders. ARCR. (2019) 40:arcr.v40.1.01. doi: 10.35946/arcr.v40.1.01 PubMed DOI PMC

National Institute on Alcohol Abuse and Alcoholism . Alcohol Use Disorder: A Comparison Between DSM–IV and DSM–5 (2021). Available at: https://www.niaaa.nih.gov/publications/brochures-and-fact-sheets/alcohol-use-disorder-comparison-between-dsm.

Kofod J, Elfving B, Nielsen EH, Mors O, Köhler-Forsberg O. Depression and inflammation: Correlation between changes in inflammatory markers with antidepressant response and long-term prognosis. Eur Neuropsychopharmacol. (2022) 54:116–25. doi: 10.1016/j.euroneuro.2021.09.006 PubMed DOI

Halaris A. Inflammation and depression but where does the inflammation come from? Cur Opin Psychiatry. (2019) 32:422–8. doi: 10.1097/YCO.0000000000000531 PubMed DOI

Leonard BE. Inflammation and depression: a causal or coincidental link to the pathophysiology? Acta Neuropsychiatr. (2018) 30:1–16. doi: 10.1017/neu.2016.69 PubMed DOI

Więdłocha M, Marcinowicz P, Krupa R, Janoska-Jaździk M, Janus M, Dębowska W, et al. . Effect of antidepressant treatment on peripheral inflammation markers – A meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry. (2018) 80:217–26. doi: 10.1016/j.pnpbp.2017.04.026 PubMed DOI

Khandaker GM, Pearson RM, Zammit S, Lewis G, Jones PB. Association of serum interleukin 6 and c-reactive protein in childhood with depression and psychosis in young adult life: a population-based longitudinal study. JAMA Psychiatry. (2014) 71:1121. doi: 10.1001/jamapsychiatry.2014.1332 PubMed DOI PMC

Wium-Andersen MK, Ørsted DD, Nielsen SF, Nordestgaard BG. Elevated C-reactive protein levels, psychological distress, and depression in 73 131 individuals. JAMA Psychiatry. (2013) 70:176. doi: 10.1001/2013.jamapsychiatry.102 PubMed DOI

Kohler O, Krogh J, Mors O, Benros ME. Inflammation in depression and the potential for anti-inflammatory treatment. Curr Neuropharmacol. (2016) 14:732–42. doi: 10.2174/1570159x14666151208113700 PubMed DOI PMC

Patel RK, Rose GM. Persistent depressive disorder, in: StatPearls (2023). Treasure Island (FL: StatPearls Publishing. Available at: http://www.ncbi.nlm.nih.gov/books/NBK541052/ (Accessed January 5, 2024). PubMed

Cipriani A, Furukawa TA, Salanti G, Chaimani A, Atkinson LZ, Ogawa Y, et al. . Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet. (2018) 391:1357–66. doi: 10.1016/S0140-6736(17)32802-7 PubMed DOI PMC

Gartlehner G, Wagner G, Matyas N, Titscher V, Greimel J, Lux L, et al. . Pharmacological and non-pharmacological treatments for major depressive disorder: review of systematic reviews. BMJ Open. (2017) 7:e014912. doi: 10.1136/bmjopen-2016-014912 PubMed DOI PMC

Khushboo SB. Antidepressants: Mechanism of action, toxicity and possible amelioration. JABB. (2017) 3:437–48. doi: 10.15406/jabb.2017.03.00082 DOI

Forneris CA, Nussbaumer-Streit B, Morgan LC, Greenblatt A, Van Noord MG, Gaynes BN, et al. . Psychological therapies for preventing seasonal affective disorder. Cochrane Database Syst Rev. (2019) 5:CD011270. doi: 10.1002/14651858.CD011270.pub3 PubMed DOI PMC

Thurfah JN, Christine, Bagaskhara PP, Alfian SD, Puspitasari IM. Dietary supplementations and depression. J Multidiscip Healthc. (2022) 15:1121–41. doi: 10.2147/JMDH.S360029 PubMed DOI PMC

Rathe M, Müller K, Sangild PT, Husby S. Clinical applications of bovine colostrum therapy: a systematic review. Nutr Rev. (2014) 72:237–54. doi: 10.1111/nure.12089 PubMed DOI

Bagwe S, Tharappel LJP, Kaur G, Buttar HS. Bovine colostrum: an emerging nutraceutical. J Complement Integr Med. (2015) 175–85. doi: 10.1515/jcim-2014-0039 PubMed DOI

Główka N, Durkalec-Michalski K, Woźniewicz M. Immunological outcomes of bovine colostrum supplementation in trained and physically active people: a systematic review and meta-analysis. Nutrients. (2020) 12:1023. doi: 10.3390/nu12041023 PubMed DOI PMC

Guberti M, Botti S, Capuzzo MT, Nardozi S, Fusco A, Cera A, et al. . Bovine colostrum applications in sick and healthy people: a systematic review. Nutrients. (2021) 13:2194. doi: 10.3390/nu13072194 PubMed DOI PMC

Rak KA, Bronkowska M. Immunological role of colostrum. Hygeia Public Health. (2014) 49:249–54.

Ghosh S, Iacucci M. Diverse immune effects of bovine colostrum and benefits in human health and disease. Nutrients. (2021) 13:3798. doi: 10.3390/nu13113798 PubMed DOI PMC

Francis GL, Upton FM, Ballard FJ, McNeil KA, Wallace JC. Insulin-like growth factors 1 and 2 in bovine colostrum. Sequences and biological activities compared with those of a potent truncated form. Biochem J. (1988) 251:95–103. doi: 10.1042/bj2510095 PubMed DOI PMC

Jones AW, March DS, Curtis F, Bridle C. Bovine colostrum supplementation and upper respiratory symptoms during exercise training: a systematic review and meta-analysis of randomised controlled trials. BMC Sports Sci Med Rehabil. (2016) 8:21. doi: 10.1186/s13102-016-0047-8 PubMed DOI PMC

Cyranka K, Rutkowski K, Mielimąka M. Applicability of Polish adaptation of MMPI-2 questionnaire in diagnosis and monitoring of psychotherapy effectiveness of patients with neurotic and personality disorders. Psychoterapia. (2016) 2:111–22.

Hsu YC, Ye Z, Dai L, Jing Y, Tsui K-L, Yip PSF, et al. . Understanding MMPI-2 response structure between schizophrenia and healthy individuals. Front Psychiatry. (2022) 13:918999. doi: 10.3389/fpsyt.2022.918999 PubMed DOI PMC

Lyons JA, Wheeler-Cox T. MMPI. MMPI-2 and PTSD: Overview of scores, scales, and profiles. J Traum Stress. (1999) 12:175–83. doi: 10.1023/A:1024710803042 PubMed DOI

World Health Organisation . International statistical classification of diseases and related health problems. Fifth edition. Geneva, Switzerland: World Health Organization; (2016). 10th revision.

Beck AT. An inventory for measuring depression. Arch Gen Psychiatry. (1961) 4:561. doi: 10.1001/archpsyc.1961.01710120031004 PubMed DOI

Kokoszka A, Jastrzębski A, Obrębski Ma. Ocena psychometrycznych właściwości polskiej wersji Kwestionariusza Zdrowia Pacjenta-9 dla osób dorosłych. Psychiatria. (2016) 13:187–93.

Zawadzki B, Popiel A, Pragłowska E. Charakterystyka psychometryczna polskiej adaptacji Kwestionariusza Depresji BDI-II Aarona T. Becka Psychologia-Etologia-Genetyka. (2009) 19:71–95.

Hamilton MA. RATING SCALE FOR DEPRESSION. J Neurol Neurosurg Psychiatry. (1960) 23:56–62. doi: 10.1136/jnnp.23.1.56 PubMed DOI PMC

Gaynes BN, Asher G, Gartlehner G, Hoffman V, Green J, Boland E, et al. . Definition of Treatment-Resistant Depression in the Medicare Population. Rockville: Agency for Healthcare Research and Quality; (2018). Available at: http://www.ahrq.gov/clinic/epcix.htm. PubMed

Dworkin RH, Turk DC, Wyrwich KW, Beaton D, Cleeland CS, Farrar JT, et al. . Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. J Pain. (2008) 9:105–21. doi: 10.1016/j.jpain.2007.09.005 PubMed DOI

Hiroe T, Kojima M, Yamamoto I, Nojima S, Kinoshita Y, Hashimoto N, et al. . Gradations of clinical severity and sensitivity to change assessed with the Beck Depression Inventory-II in Japanese patients with depression. Psychiatry Res. (2005) 135:229–35. doi: 10.1016/j.psychres.2004.03.014 PubMed DOI

Rush AJ, Trivedi MH, Ibrahim HM, Carmody TJ, Arnow B, Klein DN, et al. . The 16-Item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry. (2003) 54:573–83. doi: 10.1016/S0006-3223(02)01866-8 PubMed DOI

Podgórski T, Bartkowiak U, Pawlak M. Comparison of hematological parameters of venous and capillary blood in athletes. Trends Sport Sci. (2014) 1:39–45.

Durkalec-Michalski K, Kamińska J, Saunders B, Pokrywka A, Łoniewski I, Steffl M, et al. . Does sodium bicarbonate based extra-cellular buffering support reduce high intensity exercise-induced fatigue and enhance short-term recovery assessed by selected blood biochemical indices? Biol Sport. (2024) 41:17–27. doi: 10.5114/biolsport.2024.125591 PubMed DOI PMC

Durkalec-Michalski K, Domagalski A, Główka N, Kamińska J, Szymczak D, Podgórski T. Effect of a four-week vegan diet on performance, training efficiency and blood biochemical indices in CrossFit-trained participants. Nutrients. (2022) 14:894. doi: 10.3390/nu14040894 PubMed DOI PMC

Durkalec-Michalski K, Nowaczyk PM, Główka N, Ziobrowska A, Podgórski T. Is a four-week ketogenic diet an effective nutritional strategy in CrossFit-trained female and male athletes? Nutrients. (2021) 13:864. doi: 10.3390/nu13030864 PubMed DOI PMC

Scheller J, Chalaris A, Schmidt-Arras D, Rose-John S. The pro- and anti-inflammatory properties of the cytokine interleukin-6. Biochim Biophys Acta. (2011) 1813:878–88. doi: 10.1016/j.bbamcr.2011.01.034 PubMed DOI

Roohi E, Jaafari N, Hashemian F. On inflammatory hypothesis of depression: what is the role of IL-6 in the middle of the chaos? J Neuroinflamm. (2021) 18:45. doi: 10.1186/s12974-021-02100-7 PubMed DOI PMC

Ting EY-C, Yang AC, Tsai S-J. Role of interleukin-6 in depressive disorder. IJMS. (2020) 21:2194. doi: 10.3390/ijms21062194 PubMed DOI PMC

Hodes GE, Ménard C, Russo SJ. Integrating Interleukin-6 into depression diagnosis and treatment. Neurobiol Stress. (2016) 4:15–22. doi: 10.1016/j.ynstr.2016.03.003 PubMed DOI PMC

Liu JJ, Wei YB, Strawbridge R, Bao Y, Chang S, Shi L, et al. . Peripheral cytokine levels and response to antidepressant treatment in depression: a systematic review and meta-analysis. Mol Psychiatry. (2020) 25:339–50. doi: 10.1038/s41380-019-0474-5 PubMed DOI

Skarpańska-Stejnborn A, Cieślicka M, Dziewiecka H, Kujawski S, Marcinkiewicz A, Trzeciak J, et al. . Effects of long-term supplementation of bovine colostrum on the immune system in young female basketball players. randomized trial Nutrients. (2020) 13:118. doi: 10.3390/nu13010118 PubMed DOI PMC

Gasser M, Lissner R, Nawalaniec K, Hsiao L-L, Waaga-Gasser AM. KMP01D Demonstrates beneficial anti-inflammatory effects on immune cells: an ex vivo preclinical study of patients with colorectal cancer. Front Immunol. (2020) 11:684. doi: 10.3389/fimmu.2020.00684 PubMed DOI PMC

Sanctuary MR, Kain JN, Chen SY, Kalanetra K, Lemay DG, Rose DR, et al. . Pilot study of probiotic/colostrum supplementation on gut function in children with autism and gastrointestinal symptoms. PloS One. (2019) 14:e0210064. doi: 10.1371/journal.pone.0210064 PubMed DOI PMC

Kotsis Y, Mikellidi A, Aresti C, Persia E, Sotiropoulos A, Panagiotakos DB, et al. . A low-dose, 6-week bovine colostrum supplementation maintains performance and attenuates inflammatory indices following a Loughborough Intermittent Shuttle Test in soccer players. Eur J Nutr. (2018) 57:1181–95. doi: 10.1007/s00394-017-1401-7 PubMed DOI PMC

Cieślicka M, Ostapiuk-Karolczuk J, Buttar HS, Dziewiecka H, Kasperska A, Skarpańska-Stejnborn A. Effects of long-term supplementation of bovine colostrum on iron homeostasis, oxidative stress, and inflammation in female athletes: a placebo-controlled clinical trial. Nutrients. (2022) 15:186. doi: 10.3390/nu15010186 PubMed DOI PMC

Shing CM, Peake J, Suzuki K, Okutsu M, Pereira R, Stevenson L, et al. . Effects of bovine colostrum supplementation on immune variables in highly trained cyclists. J Appl Physiol. (2007) 102:1113–22. doi: 10.1152/japplphysiol.00553.2006 PubMed DOI

Carol A, Witkamp RF, Wichers HJ, Mensink M. Bovine colostrum supplementation’s lack of effect on immune variables during short-term intense exercise in well-trained athletes. Int J Sport Nutr Exerc Metab. (2011) 21:135–45. doi: 10.1123/ijsnem.21.2.135 PubMed DOI

Vulser H, Lemogne C, Boutouyrie P, Côté F, Perier M-C, Van Sloten T, et al. . Depression, antidepressants and low hemoglobin level in the Paris Prospective Study III: A cross-sectional analysis. Prev Med. (2020) 135:106050. doi: 10.1016/j.ypmed.2020.106050 PubMed DOI

Jones AW, March DS, Thatcher R, Diment B, Walsh NP, Davison G. The effects of bovine colostrum supplementation on in vivo immunity following prolonged exercise: a randomised controlled trial. Eur J Nutr. (2019) 58:335–44. doi: 10.1007/s00394-017-1597-6 PubMed DOI PMC

March DS, Jones AW, Thatcher R, Davison G. The effect of bovine colostrum supplementation on intestinal injury and circulating intestinal bacterial DNA following exercise in the heat. Eur J Nutr. (2018) 58(4):1441–51. doi: 10.1007/s00394-018-1670-9 PubMed DOI PMC

Lamers F, Milaneschi Y, Smit JH, Schoevers RA, Wittenberg G, Penninx BWJH. Longitudinal association between depression and inflammatory markers: results from the Netherlands study of depression and anxiety. Biol Psychiatry. (2019) 85:829–37. doi: 10.1016/j.biopsych.2018.12.020 PubMed DOI

Harris MTH, Laks J, Stahl N, Bagley SM, Saia K, Wechsberg WM. Gender dynamics in substance use and treatment. Med Clin North Am. (2022) 106:219–34. doi: 10.1016/j.mcna.2021.08.007 PubMed DOI PMC

Green CA. Gender and use of substance abuse treatment services. Alcohol Res Health. (2006) 29:55–62. PubMed PMC

Herbeck DM, Fitek DJ, Svikis DS, Montoya ID, Marcus SC, West JC. Treatment compliance in patients with comorbid psychiatric and substance use disorders. Am J Addict. (2005) 14:195–207. doi: 10.1080/10550490590949488 PubMed DOI PMC

Twelve-Week Colostrum Bovinum Supplementation Supports Aerobic Capacity but has No Effect on Body Composition in Endurance-Trained Males: A Randomized Placebo-Controlled Crossover Study